American Journal of Obstetrics & Gynecology
Volume 202, Issue 5 , Pages 439.e1-439.e10, May 2010

Use of herbal treatments in pregnancy

  • Carol Louik, ScD

      Affiliations

    • Slone Epidemiology Center, Boston University, Boston, MA
    • Corresponding Author InformationReprints: Carol Louik, ScD, Slone Epidemiology Center at Boston University, 1010 Commonwealth Ave., Boston, MA 02215
  • ,
  • Paula Gardiner, MD, MPH

      Affiliations

    • Department of Family Medicine, Boston University, Boston, MA
  • ,
  • Katherine Kelley, RPh, MPH

      Affiliations

    • Slone Epidemiology Center, Boston University, Boston, MA
  • ,
  • Allen A. Mitchell, MD

      Affiliations

    • Slone Epidemiology Center, Boston University, Boston, MA

Received 25 June 2009; received in revised form 7 October 2009; accepted 20 January 2010.

Objective

Interest in herbal treatments has increased without data on safety, efficacy, or rates of use in pregnancy. We examined antenatal herbal and natural product use among mothers of nonmalformed infants in 5 geographic centers.

Study design

We used data on nonmalformed infants from the Slone Epidemiology Center's case-control surveillance program for birth defects to examine rates and predictors of herbal use. Exposures were identified through maternal interview. In addition to overall use, 5 categories based on traditional uses and 2 natural product categories were created; topical products and herbal-containing multivitamins were excluded.

Results

Among 4866 mothers of nonmalformed infants, 282 (5.8%) reported use of herbal or natural treatments. Use varied by study center and increased with increasing age.

Conclusion

Although rates of use are low, there remains a need for investigation of the safety of these products. Given sparse data on efficacy, even small risks might well outweigh benefits.

Key words: complementary medicine, drug safety, herbal treatments, pregnancy

 

 This study was supported in part by the National Institute of Child Health and Human Development Grant HD27697; National Heart, Lung, and Blood Institute Grant HL 50763; and Cooperative Agreement no. U50/CCU113247 with the Centers for Disease Control and Prevention through the Massachusetts Department of Public Health. Additional support for the Slone Epidemiology Center Birth Defects Study was provided by Aventis Inc and Sanofi Pasteur Inc.

 Cite this article as: Louik C, Gardiner P, Kelley K, et al. Use of herbal treatments in pregnancy. Am J Obstet Gynecol 2010;202:439.e1-10.

PII: S0002-9378(10)00085-2

doi:10.1016/j.ajog.2010.01.055

American Journal of Obstetrics & Gynecology
Volume 202, Issue 5 , Pages 439.e1-439.e10, May 2010